Clinical-Trial Cannabis and Placebo Shipped to Support Canadian Clinical Research

Following receipt of an import permit from Health Canada, RTI, the contracted licensed distributor for NDSP, shipped placebo cannabis to Aqualitas, a Canadian licensed cannabis producer. Aqualitas will process the placebo and 19,926 grams of cannabis containing 20% THC into 0.5 gram pre-rolled cigarettes. The shipment marks a logistical step in preparing cannabis and placebo materials for a Canadian clinical trial. The supplied information does not describe the trial design, participants, research question, outcomes, or the composition of the placebo beyond identifying it as placebo cannabis.